Skip to main content
Clinical Trials/NCT01589679
NCT01589679TerminatedNot Applicable

Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial

Dynasplint Systems, Inc.6 sites in 1 country40 target enrollmentStarted: April 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
40
Locations
6
Primary Endpoint
A Repeated Measures Analysis of Variance (ANOVA)

Study Overview

Brief Summary

To determine the efficacy of Metatarsal Dynasplint Sytem (MTP) in reducing contracture of hallux limitus secondary to Bunionectomy, in a longitudinal, controlled trial.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis 1st MTJ Contracture following Bunionectomy

Exclusion Criteria

  • Current treatment with Botulinium Toxin-A (Botox), lower extremity
  • Current treatment Fluoroquinolones (antibiotic medication)
  • Current use of muscle relaxant medications
  • Fibromyalgia
  • Stroke, CVA, Brain Injury, Spinal Cord Injury, or any neural pathology causing plasticity or hypertonicity
  • Treatment with electrical stimulation assisting ambulation (i.e Bioness, WalkAide, Parastep, etc.)

Outcomes

Primary Outcomes

A Repeated Measures Analysis of Variance (ANOVA)

Time Frame: 12 months

ANOVA will be performed to measure different in category, pain, duration to full restoration of active range of motion(AROM).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials

Contracture Reduction Following... | Clinical Trial